Abstract
Coronary artery disease is the leading cause of complications and death in the United States and other Western countries, and stress myocardial perfusion study is an important component of the clinical evaluation, stratification, and management. This imaging technique is a well-established modality and has been widely used for the past three decades. New quantitative techniques for the assessment of ventricular function using quantitative gated single-photon emission computed tomography in addition to myocardial perfusion will potentially enhance the role of nuclear cardiology in the management of these patients. This review summarizes the current knowledge of the diagnostic and prognostic uses of stress myocardial perfusion imaging using exercise and pharmacological stress in patients with stable coronary artery disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
